These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 10989245

  • 1. The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women.
    Kökçü A, Cetinkaya MB, Yanik F, Alper T, Malatyalioğlu E.
    Maturitas; 2000 Jul 31; 36(1):75-80. PubMed ID: 10989245
    [Abstract] [Full Text] [Related]

  • 2. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 31; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 3. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May 31; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 4. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH, Pan HA, Wang ST, Hsu CC, Chang FM, Huang KE.
    Climacteric; 2001 Dec 31; 4(4):314-9. PubMed ID: 11770188
    [Abstract] [Full Text] [Related]

  • 5. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar 31; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S, Moghasemi M, Faghihzadeh S.
    Climacteric; 2010 Apr 31; 13(2):147-56. PubMed ID: 19731119
    [Abstract] [Full Text] [Related]

  • 7. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
    Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martínez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA.
    Maturitas; 2000 Feb 15; 34(2):161-8. PubMed ID: 10714911
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 10. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep 15; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 11. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 12. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
    Ziaei S, Moaya M, Faghihzadeh S.
    Climacteric; 2010 Jun 10; 13(3):249-53. PubMed ID: 19848555
    [Abstract] [Full Text] [Related]

  • 13. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD, Landgren BM, Rymer J, Helmond FA, OPAL Investigators.
    Am J Obstet Gynecol; 2006 Nov 10; 195(5):1320-7. PubMed ID: 16875644
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F, Dilek U, Pata O, Dilek S.
    J Sex Med; 2008 Jan 10; 5(1):132-8. PubMed ID: 17961145
    [Abstract] [Full Text] [Related]

  • 15. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial.
    Ossewaarde ME, Dallinga-Thie GM, Bots ML, van der Schouw YT, Rabelink TJ, Grobbee DE, Westerveld HT.
    Eur J Clin Invest; 2003 May 10; 33(5):376-82. PubMed ID: 12713450
    [Abstract] [Full Text] [Related]

  • 16. Postmenopausal hormone therapy and mammographic breast density.
    Marchesoni D, Driul L, Ianni A, Fabiani G, Della Martina M, Zuiani C, Bazzocchi M.
    Maturitas; 2006 Jan 10; 53(1):59-64. PubMed ID: 15939560
    [Abstract] [Full Text] [Related]

  • 17. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.
    Huber J, Palacios S, Berglund L, Hänggi W, Sathanandan SM, Christau S, Helmond F.
    BJOG; 2002 Aug 10; 109(8):886-93. PubMed ID: 12197367
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 10; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 20. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
    Laan E, van Lunsen RH, Everaerd W.
    Climacteric; 2001 Mar 10; 4(1):28-41. PubMed ID: 11379375
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.